Tag: phosphoramidite market trends

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

#Phosphoramidite Market Set To Climb From $1.14 Billion In 2026 To $1.49 Billion By 2030#_x000D_

The phosphoramidite market has demonstrated strong growth in recent years. Its value is projected to increase from $1.07 billion in 2025 to $1.15 billion in 2026, progressing at a compound annual growth rate (CAGR) of 7.1%. The expansion observed in the past can be attributed to several factors including a surge in DNA sequencing activities, increased funding for academic research, wider application of synthetic nucleic acids, advancements in solid-phase synthesis techniques, and a rising requirement for molecular diagnostics._x000D_

_x000D_

The phosphoramidite market is poised for substantial growth over the next few years. This market is expected to reach $1.5 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.9%. This growth throughout the forecast period stems from factors such as the expansion of RNA-based therapeutics, advancements in gene editing technologies, increased investment in pharmaceutical research and development, a rising demand for custom oligonucleotides, and the scaling up of automated synthesis platforms. Furthermore, significant trends anticipated during the forecast period involve a growing demand for oligonucleotide synthesis materials, the expansion of gene therapy and RNA therapeutics, their increasing utilization in diagnostic and research applications, the rising adoption of automated solid-phase synthesis, and a heightened focus on high-purity chemical inputs._x000D_

_x000D_

#Get A Free Sample Report With In-Depth Market Insights:#_x000D_

https://thebusinessresearchcompany.com/sample_request?id=71215212&type=smp&name=Phosphoramidite%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Phosphoramidite Market Growth Drivers: What’s Behind The Acceleration?#_x000D_

The anticipated expansion of the biopharmaceutical sector is set to fuel the growth of the phosphoramidite market in the future. This sector encompasses the industry involved in the research, development, production, and commercialization of medical products derived from biological sources, including vaccines, gene therapies, monoclonal antibodies, and recombinant proteins. The growth of the biopharmaceutical sector is attributed to advancements in biotechnology, the increasing prevalence of chronic diseases, and rising investments in research and development. Biotechnology innovations, such as gene editing and monoclonal antibody therapies, have enabled the creation of more effective and targeted treatments. For example, in October 2025, the Office for National Statistics, a UK-based government department, reported that in 2024, the UK life sciences industry consisted of 6,170 businesses operating across 7,320 sites, employing 359,600 people and generating $191 billion (£146.9 billion) in turnover. The medical technology subsector was the largest by both company count and workforce, accounting for 60% of all companies and 55% of total employment. Consequently, the expanding biopharmaceutical sector is a significant driver for the growth of the phosphoramidite market._x000D_

_x000D_

#Phosphoramidite Market Segments: Where Is Growth Concentrated?#_x000D_

The phosphoramidite market covered in this report is segmented – _x000D_

_x000D_

1) By Type: Deoxyribonucleic Acid (DNA) Phosphoramidites, Ribonucleic Acid (RNA) Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites, Other Types_x000D_

2) By Synthesis Method: H-Phosphonate Method, Phosphoramidite Method, Trivalent Phosphorus Compounds Method_x000D_

3) By Application: Gene Synthesis, Deoxyribonucleic Acid (DNA) Sequencing, Deoxyribonucleic Acid (DNA) Amplification_x000D_

4) By End-User: Academic Research, Pharmaceutical Industry, Biotechnology Industry_x000D_

_x000D_

Subsegments:_x000D_

1) By Deoxyribonucleic Acid (DNA) Phosphoramidites: Standard DNA Phosphoramidites, Degenerate DNA Phosphoramidites, Methylated DNA Phosphoramidites, Backbone-Modified DNA Phosphoramidites_x000D_

2) By Ribonucleic Acid (RNA) Phosphoramidites: Standard RNA Phosphoramidites, 2′-O-Methyl RNA Phosphoramidites, 2′-Fluoro RNA Phosphoramidites, 2′-O-TBDMS Protected RNA Phosphoramidites_x000D_

3) By Labeled Phosphoramidites: Fluorescent-Labeled Phosphoramidites, Biotin-Labeled Phosphoramidites, Digoxigenin-Labeled Phosphoramidites, Radioisotope-Labeled Phosphoramidites_x000D_

4) By Modifier Phosphoramidites: Amine-Modified Phosphoramidites, Thiol-Modified Phosphoramidites, Spacer Phosphoramidites, Azide-Modified Phosphoramidites_x000D_

5) By Other Types: Chimeric Phosphoramidites, Phosphorothioate Phosphoramidites, PEGylated Phosphoramidites, Photo-Cleavable Phosphoramidites_x000D_

_x000D_

#Phosphoramidite Market Trends: What’s Defining The Industry’s Next Phase?#_x000D_

Key companies within the phosphoramidite market are concentrating on developing advanced DNA synthesis methods, such as utilizing convertible-preferred stock financing rounds, to boost the adoption and progress of Gibson SOLA technology for rapid DNA and mRNA synthesis. Convertible-preferred stock financing is defined as a capital-raising approach where a company issues preferred shares that can subsequently be converted into a predetermined count of common shares. For example, in March 2025, Telesis Bio Inc., a US-based biotechnology company, announced it had secured up to $21 million in new financing from several strategic investors to accelerate the commercialization of its next-generation enzymatic DNA synthesis platform, Gibson SOLA. This funding aims to scale the company’s fully enzymatic DNA synthesis technology, expand its research and development along with manufacturing capabilities, and broaden access to rapid, customizable long-DNA production. The company employs a proprietary enzymatic method that enables quick and precise synthesis of long DNA sequences, thereby addressing current limitations linked with traditional phosphoramidite-based approaches._x000D_

_x000D_

#Phosphoramidite Market Key Participants And Competitive Landscape#_x000D_

Major companies operating in the phosphoramidite market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Aragen Life Sciences, Twist Bioscience, Innovassynth Technologies (I) Ltd., Tokyo Chemical Industry Co. Ltd. (TCI), Aurigene Services, Eurofins Genomics, LGC Biosearch Technologies, Link Technologies Ltd., Creative Biolabs, Biosynth Carbosynth, TriLink BioTechnologies, ChemGenes Corporation, Berry & Associates Inc., Lumiprobe Corporation, Hongene Biotech Corporation, Carbolink India Pvt. Ltd., PolyOrg Inc., Glen Research, Gene Link Inc., emp BIOTECH GmbH _x000D_

_x000D_

#View The Full Phosphoramidite Market Report:#_x000D_

https://thebusinessresearchcompany.com/report/phosphoramidite-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Phosphoramidite Market Regional Analysis And Leading Geography#_x000D_

North America was the largest region in the phosphoramidite market in 2025. Europe is expected to be the fastest-growing region during the forecast period. The regions covered in the phosphoramidite market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Reach Out To Our Team:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas: +1 310-496-7795_x000D_

Asia: +44 7882 955267 & +91 8897263534_x000D_

Europe: +44 7882 955267_x000D_

Email us at: marketing@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Phosphoramidite Market Value Analysis: What Growth Is Expected Over The Forecast Period?

The phosphoramidite market has experienced notable expansion over recent years, with its value projected to increase from $1.07 billion in 2025 to $1.15 billion in 2026, reflecting a compound annual growth rate (CAGR) of 7.1%. This historical growth has been driven by several factors, including a rise in DNA sequencing activities, the broadening of academic research funding, a greater utilization of synthetic nucleic acids, advances in solid-phase synthesis methods, and a growing need for molecular diagnostics.

The phosphoramidite sector is projected to experience robust expansion over the coming years, with its valuation anticipated to reach $1.5 billion by 2030, reflecting a compound annual growth rate (CAGR) of 6.9%. This forecast period growth is driven by factors such as the proliferation of RNA-based therapeutics, advancements in gene editing techniques, heightened investment in pharmaceutical research and development, an increased need for tailor-made oligonucleotides, and the expansion of automated synthesis platforms. Among the key trends shaping the market are the growing requirement for materials used in oligonucleotide synthesis, the broadening scope of gene therapy and RNA-focused treatments, their rising utility in diagnostic and research contexts, the widespread uptake of automated solid-phase synthesis processes, and an enhanced emphasis on high-purity chemical components.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22096&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Phosphoramidite Market Development Factors: Which Trends Are Supporting Demand?

The anticipated growth of the phosphoramidite market is being driven forward by the expansion of the biopharmaceutical sector. This sector encompasses the research, development, manufacturing, and marketing of biologically based medical products, such as vaccines, gene therapies, monoclonal antibodies, and recombinant proteins. Its expansion is fueled by progress in biotechnology, a rising incidence of chronic diseases, and greater investments in research and development. Innovations in biotechnology—including gene editing and monoclonal antibody therapies—have led to more effective and precisely targeted treatments. As an example, in October 2025, the UK-based Office for National Statistics reported that the country’s life sciences industry in 2024 consisted of 6,170 businesses across 7,320 sites, employing 359,600 people and generating £146.9 billion ($191 billion) in turnover. The medical technology subsector was the largest in terms of both company count and workforce, accounting for 60% of all firms and 55% of total employment. Consequently, the ongoing expansion of the biopharmaceutical sector is significantly boosting the phosphoramidite market.

Phosphoramidite Market Segment Landscape: Which Areas Lead Market Development?

The phosphoramidite market covered in this report is segmented –

1) By Type: Deoxyribonucleic Acid (DNA) Phosphoramidites, Ribonucleic Acid (RNA) Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites, Other Types

2) By Synthesis Method: H-Phosphonate Method, Phosphoramidite Method, Trivalent Phosphorus Compounds Method

3) By Application: Gene Synthesis, Deoxyribonucleic Acid (DNA) Sequencing, Deoxyribonucleic Acid (DNA) Amplification

4) By End-User: Academic Research, Pharmaceutical Industry, Biotechnology Industry

Subsegments:

1) By Deoxyribonucleic Acid (DNA) Phosphoramidites: Standard DNA Phosphoramidites, Degenerate DNA Phosphoramidites, Methylated DNA Phosphoramidites, Backbone-Modified DNA Phosphoramidites

2) By Ribonucleic Acid (RNA) Phosphoramidites: Standard RNA Phosphoramidites, 2′-O-Methyl RNA Phosphoramidites, 2′-Fluoro RNA Phosphoramidites, 2′-O-TBDMS Protected RNA Phosphoramidites

3) By Labeled Phosphoramidites: Fluorescent-Labeled Phosphoramidites, Biotin-Labeled Phosphoramidites, Digoxigenin-Labeled Phosphoramidites, Radioisotope-Labeled Phosphoramidites

4) By Modifier Phosphoramidites: Amine-Modified Phosphoramidites, Thiol-Modified Phosphoramidites, Spacer Phosphoramidites, Azide-Modified Phosphoramidites

5) By Other Types: Chimeric Phosphoramidites, Phosphorothioate Phosphoramidites, PEGylated Phosphoramidites, Photo-Cleavable Phosphoramidites

Phosphoramidite Market Transformation Trends: Which Innovations Are Driving Change?

Leading players in the phosphoramidite market are concentrating on developing advanced DNA synthesis techniques, including convertible-preferred stock financing rounds, to boost the adoption and progress of Gibson SOLA technology for fast DNA and mRNA synthesis. Convertible-preferred stock financing is a capital-raising strategy where firms issue preferred shares that can be transformed into a set number of common shares at a later time. For example, in March 2025, Telesis Bio Inc., a biotechnology company based in the US, announced it had obtained up to $21 million in new funding to speed up the commercialization of its innovative enzymatic DNA synthesis platform, Gibson SOLA, backed by several strategic investors. This investment is intended to grow the firm’s fully enzymatic DNA synthesis technology, enhance its research, development, and manufacturing capacities, and improve access to quick, customizable long-DNA production. The company employs a proprietary enzymatic method that allows for the rapid and accurate synthesis of extended DNA sequences, tackling existing limitations linked to traditional phosphoramidite-based processes.

Phosphoramidite Market Industry Leaders And Market Competition

Major companies operating in the phosphoramidite market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Aragen Life Sciences, Twist Bioscience, Innovassynth Technologies (I) Ltd., Tokyo Chemical Industry Co. Ltd. (TCI), Aurigene Services, Eurofins Genomics, LGC Biosearch Technologies, Link Technologies Ltd., Creative Biolabs, Biosynth Carbosynth, TriLink BioTechnologies, ChemGenes Corporation, Berry & Associates Inc., Lumiprobe Corporation, Hongene Biotech Corporation, Carbolink India Pvt. Ltd., PolyOrg Inc., Glen Research, Gene Link Inc., emp BIOTECH GmbH

Access The Complete Phosphoramidite Market Report:

https://www.thebusinessresearchcompany.com/report/phosphoramidite-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Phosphoramidite Market Regional Distribution: Which Areas Drive Market Expansion?

North America was the largest region in the phosphoramidite market in 2025. Europe is expected to be the fastest-growing region during the forecast period. The regions covered in the phosphoramidite market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Market Value Trend Is Expected For The Phosphoramidite Market From 2026 To 2030?

The phosphoramidite market size has demonstrated robust growth in recent years. It is projected to expand from $1.07 billion in 2025 to $1.15 billion in 2026, recording a compound annual growth rate (CAGR) of 7.1%. This historical expansion can be attributed to various factors, including the increasing number of DNA sequencing activities, an rise in academic research funding, wider adoption of synthetic nucleic acids, advancements in solid-phase synthesis techniques, and a growing demand for molecular diagnostics.

The phosphoramidite market size is anticipated to undergo significant expansion over the forthcoming years. It is projected to reach $1.5 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 6.9%. This expansion during the forecast period can be attributed to the broadening application of RNA-based therapeutics, advancements in gene editing technologies, augmented pharmaceutical R&D investment, a rising need for custom oligonucleotides, and the scaling of automated synthesis platforms. Prominent trends expected in this period include an increasing demand for oligonucleotide synthesis materials, the growing prevalence of gene therapy and RNA therapeutics, their expanding utility in diagnostic and research applications, the increasing adoption of automated solid-phase synthesis, and a heightened emphasis on high-purity chemical inputs.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22096&type=smp

Which Strategic Drivers Are Supporting The Phosphoramidite Market Development?

The expanding biopharmaceutical sector is projected to fuel the growth of the phosphoramidite market in the upcoming period. This sector broadly covers the industry involved in the research, development, production, and commercialization of medical products derived from biological sources, including vaccines, gene therapies, monoclonal antibodies, and recombinant proteins. The expansion of the biopharmaceutical sector is primarily attributed to advancements in biotechnology, the increasing global prevalence of chronic diseases, and escalating investments in research and development. Innovations in biotechnology, such as gene editing and monoclonal antibody therapies, have facilitated the development of more effective and precisely targeted treatments. For instance, in October 2025, the Office for National statistics, a UK-based government department, reported that in 2024, the UK life sciences industry comprised 6,170 businesses operating across 7,320 sites, employing 359,600 people and generating $191 billion (£146.9 billion) in turnover. Among these, medical technology stood out as the largest subsector by both company count and workforce, representing 60% of all companies and 55% of total employment. Therefore, the significant growth of the biopharmaceutical sector is a key factor driving the phosphoramidite market’s expansion.

What Are The Core Segment Classifications In The Phosphoramidite Market?

The phosphoramidite market covered in this report is segmented –

1) By Type: Deoxyribonucleic Acid (DNA) Phosphoramidites, Ribonucleic Acid (RNA) Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites, Other Types

2) By Synthesis Method: H-Phosphonate Method, Phosphoramidite Method, Trivalent Phosphorus Compounds Method

3) By Application: Gene Synthesis, Deoxyribonucleic Acid (DNA) Sequencing, Deoxyribonucleic Acid (DNA) Amplification

4) By End-User: Academic Research, Pharmaceutical Industry, Biotechnology Industry

Subsegments:

1) By Deoxyribonucleic Acid (DNA) Phosphoramidites: Standard DNA Phosphoramidites, Degenerate DNA Phosphoramidites, Methylated DNA Phosphoramidites, Backbone-Modified DNA Phosphoramidites

2) By Ribonucleic Acid (RNA) Phosphoramidites: Standard RNA Phosphoramidites, 2′-O-Methyl RNA Phosphoramidites, 2′-Fluoro RNA Phosphoramidites, 2′-O-TBDMS Protected RNA Phosphoramidites

3) By Labeled Phosphoramidites: Fluorescent-Labeled Phosphoramidites, Biotin-Labeled Phosphoramidites, Digoxigenin-Labeled Phosphoramidites, Radioisotope-Labeled Phosphoramidites

4) By Modifier Phosphoramidites: Amine-Modified Phosphoramidites, Thiol-Modified Phosphoramidites, Spacer Phosphoramidites, Azide-Modified Phosphoramidites

5) By Other Types: Chimeric Phosphoramidites, Phosphorothioate Phosphoramidites, PEGylated Phosphoramidites, Photo-Cleavable Phosphoramidites

Which Trends Are Guiding The Development Of The Phosphoramidite Market?

Major companies in the phosphoramidite market are prioritizing the development of advanced DNA synthesis methods, such as utilizing convertible-preferred stock financing rounds to enhance the adoption and advancement of Gibson SOLA technology for quick DNA and mRNA synthesis. Convertible-preferred stock financing represents a capital-raising strategy where a company issues preferred shares that possess the option to be converted into a predetermined quantity of common shares later. For instance, in March 2025, Telesis Bio Inc., a US-based biotechnology company, announced it had secured up to $21 million in new funding to expedite the commercialization of its next-generation enzymatic DNA synthesis platform, Gibson SOLA, with backing from several strategic investors. This funding is allocated to expand the company’s fully enzymatic DNA synthesis technology, grow its research and development and manufacturing capabilities, and broaden access to rapid, customizable long-DNA production. The company employs a proprietary enzymatic method that enables the fast and precise synthesis of long DNA sequences, addressing existing limitations associated with traditional phosphoramidite-based approaches.

Which Companies Are Engaged In The Phosphoramidite Market Environment?

Major companies operating in the phosphoramidite market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Aragen Life Sciences, Twist Bioscience, Innovassynth Technologies (I) Ltd., Tokyo Chemical Industry Co. Ltd. (TCI), Aurigene Services, Eurofins Genomics, LGC Biosearch Technologies, Link Technologies Ltd., Creative Biolabs, Biosynth Carbosynth, TriLink BioTechnologies, ChemGenes Corporation, Berry & Associates Inc., Lumiprobe Corporation, Hongene Biotech Corporation, Carbolink India Pvt. Ltd., PolyOrg Inc., Glen Research, Gene Link Inc., emp BIOTECH GmbH

Access The Complete Phosphoramidite Market Report:

https://www.thebusinessresearchcompany.com/report/phosphoramidite-global-market-report

Which Regional Market Leads The Phosphoramidite Market?

North America was the largest region in the phosphoramidite market in 2025. Europe is expected to be the fastest-growing region during the forecast period. The regions covered in the phosphoramidite market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Phosphoramidite Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=22096&type=smp

Browse Through More Reports Similar to the Global Phosphoramidite Market 2026, By The Business Research Company

Phosgene Market Report 2026

https://www.thebusinessresearchcompany.com/report/phosgene-global-market-report

Phosphoric Acid Market Report 2026

https://www.thebusinessresearchcompany.com/report/phosphoric-acid-global-market-report

Phosphonates Market Report 2026

https://www.thebusinessresearchcompany.com/report/phosphonates-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Large Will The Phosphoramidite Market Be By 2030 Compared To Its 2026 Market Size?

The phosphoramidite market has witnessed substantial expansion in recent years. It is anticipated to grow from $1.07 billion in 2025 to $1.15 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.1%. The historical increase can be attributed to factors such as a surge in DNA sequencing activities, greater academic research funding, the increased use of synthetic nucleic acids, the development of solid-phase synthesis techniques, and rising demand for molecular diagnostics.

The phosphoramidite market is projected to experience robust expansion over the coming years. By 2030, its valuation is forecast to reach $1.5 billion, demonstrating a compound annual growth rate (CAGR) of 6.9%. This anticipated growth during the forecast timeframe is primarily driven by factors such as the broadening scope of RNA-based treatments, advancements in gene editing technologies, increased funding for pharmaceutical research and development, a growing need for customized oligonucleotides, and the scaling up of automated synthesis systems. Key trends emerging over the projection period encompass an escalating requirement for materials used in oligonucleotide synthesis, the widening application of gene therapy and RNA therapeutics, expanded utilization in both diagnostic and research contexts, the increasing embrace of automated solid-phase synthesis, and a heightened emphasis on chemical inputs of superior purity.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22096&type=smp

What Significant Factors Are Influencing The Phosphoramidite Market Expansion?

The phosphoramidite market is anticipated to see growth propelled by the expansion of the biopharmaceutical sector. This sector involves the research, development, production, and commercialization of biologically derived medical products, such as vaccines, gene therapies, monoclonal antibodies, and recombinant proteins. The enlargement of the biopharmaceutical sector stems from advancements in biotechnology, an increase in the prevalence of chronic diseases, and rising investments in research and development. Biotechnology innovations like gene editing and monoclonal antibody therapies have led to more effective and targeted treatments. For instance, the Office for National Statistics, a UK-based government department, reported in October 2025 that in 2024, the UK life sciences industry comprised 6,170 businesses operating across 7,320 sites, employing 359,600 people and generating $191 billion (£146.9 billion) in turnover. The medical technology subsector was the largest, representing 60% of all companies and 55% of total employment. Therefore, the expansion of the biopharmaceutical sector is a significant driver for the growth of the phosphoramidite market.

How Is The Phosphoramidite Market Categorized Across Its Segment Groups?

The phosphoramidite market covered in this report is segmented –

1) By Type: Deoxyribonucleic Acid (DNA) Phosphoramidites, Ribonucleic Acid (RNA) Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites, Other Types

2) By Synthesis Method: H-Phosphonate Method, Phosphoramidite Method, Trivalent Phosphorus Compounds Method

3) By Application: Gene Synthesis, Deoxyribonucleic Acid (DNA) Sequencing, Deoxyribonucleic Acid (DNA) Amplification

4) By End-User: Academic Research, Pharmaceutical Industry, Biotechnology Industry

Subsegments:

1) By Deoxyribonucleic Acid (DNA) Phosphoramidites: Standard DNA Phosphoramidites, Degenerate DNA Phosphoramidites, Methylated DNA Phosphoramidites, Backbone-Modified DNA Phosphoramidites

2) By Ribonucleic Acid (RNA) Phosphoramidites: Standard RNA Phosphoramidites, 2′-O-Methyl RNA Phosphoramidites, 2′-Fluoro RNA Phosphoramidites, 2′-O-TBDMS Protected RNA Phosphoramidites

3) By Labeled Phosphoramidites: Fluorescent-Labeled Phosphoramidites, Biotin-Labeled Phosphoramidites, Digoxigenin-Labeled Phosphoramidites, Radioisotope-Labeled Phosphoramidites

4) By Modifier Phosphoramidites: Amine-Modified Phosphoramidites, Thiol-Modified Phosphoramidites, Spacer Phosphoramidites, Azide-Modified Phosphoramidites

5) By Other Types: Chimeric Phosphoramidites, Phosphorothioate Phosphoramidites, PEGylated Phosphoramidites, Photo-Cleavable Phosphoramidites

What Trends Are Affecting The Growth Of The Phosphoramidite Market?

Within the phosphoramidite market, prominent companies are increasingly focused on developing advanced DNA synthesis methods, such as utilizing convertible-preferred stock financing rounds, to boost the adoption and progress of Gibson SOLA technology for rapid DNA and mRNA synthesis. Convertible-preferred stock financing is defined as a capital-raising technique where a company issues preferred shares that have the option to be converted into a predetermined number of common shares later on. For example, in March 2025, Telesis Bio Inc., a US-based biotechnology company, announced it had secured up to $21 million in new financing, supported by several strategic investors, to speed up the commercialization of its next-generation enzymatic DNA synthesis platform, Gibson SOLA. This funding is designed to scale the company’s fully enzymatic DNA synthesis technology, expand its R&D and manufacturing capabilities, and broaden access to rapid, customizable long-DNA production. The company employs a unique enzymatic approach that allows for the fast and precise synthesis of long DNA sequences, thereby addressing current limitations found in traditional phosphoramidite-based methods.

Which Firms Are Influencing Competition In The Phosphoramidite Market?

Major companies operating in the phosphoramidite market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Aragen Life Sciences, Twist Bioscience, Innovassynth Technologies (I) Ltd., Tokyo Chemical Industry Co. Ltd. (TCI), Aurigene Services, Eurofins Genomics, LGC Biosearch Technologies, Link Technologies Ltd., Creative Biolabs, Biosynth Carbosynth, TriLink BioTechnologies, ChemGenes Corporation, Berry & Associates Inc., Lumiprobe Corporation, Hongene Biotech Corporation, Carbolink India Pvt. Ltd., PolyOrg Inc., Glen Research, Gene Link Inc., emp BIOTECH GmbH

Get The Full Phosphoramidite Market Report:

https://www.thebusinessresearchcompany.com/report/phosphoramidite-global-market-report

Which Region Holds The Highest Market Share In The Phosphoramidite Market?

North America was the largest region in the phosphoramidite market in 2025. Europe is expected to be the fastest-growing region during the forecast period. The regions covered in the phosphoramidite market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Phosphoramidite Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/phosphoramidite-global-market-report

Browse Through More Reports Similar to the Global Phosphoramidite Market 2026, By The Business Research Company

Phosgene Market Report 2026

https://www.thebusinessresearchcompany.com/report/phosgene-global-market-report

Phosphoric Acid Market Report 2026

https://www.thebusinessresearchcompany.com/report/phosphoric-acid-global-market-report

Phosphonates Market Report 2026

https://www.thebusinessresearchcompany.com/report/phosphonates-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Phosphoramidite Market Over The 2026–2030 Period?

The phosphoramidite market has experienced robust expansion over the past few years. It is projected to expand from $1.07 billion in 2025 to $1.15 billion by 2026, registering a compound annual growth rate (CAGR) of 7.1%. Historically, this growth can be attributed to an increase in DNA sequencing activities, the expansion of academic research funding, a greater use of synthetic nucleic acids, the development of solid-phase synthesis techniques, and rising demand for molecular diagnostics.

The phosphoramidite market size is anticipated to experience robust expansion over the coming years. This market is projected to reach a valuation of $1.5 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.9%. Key drivers for this growth during the projection period include the broadening scope of RNA-based therapeutics, advancements in gene editing technologies, heightened investment in pharmaceutical research and development, an increasing need for custom oligonucleotides, and the expansion of automated synthesis platforms. Significant trends identified for the forecast timeframe encompass an escalating requirement for oligonucleotide synthesis materials, the enlargement of gene therapy and RNA therapeutics applications, wider incorporation into diagnostic and research uses, increasing integration of automated solid-phase synthesis methods, and a sharpened emphasis on chemical inputs of high purity.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22096&type=smp

What Underlying Factors Are Accelerating The Growth Of The Phosphoramidite Market?

The expanding biopharmaceutical sector is anticipated to drive the future growth of the phosphoramidite market. This sector refers to the industry engaged in the research, development, production, and commercialization of biologically derived medical products, encompassing vaccines, gene therapies, monoclonal antibodies, and recombinant proteins. The expansion of the biopharmaceutical sector is a result of advancements in biotechnology, the increasing prevalence of chronic diseases, and greater investments in research and development. Biotechnology innovations, such as gene editing and monoclonal antibody therapies, have led to more effective and targeted treatments. For instance, in October 2025, the Office for National statistics, a UK-based government department, reported that in 2024, the UK life sciences industry consisted of 6,170 businesses operating across 7,320 sites, employing 359,600 people, and generating $191 billion (£146.9 billion) in turnover. The medical technology subsector was the largest by both company count and workforce, accounting for 60% of all companies and 55% of total employment. Thus, the growth of the phosphoramidite market is being propelled by the expansion of the biopharmaceutical sector.

How Is The Phosphoramidite Market Segmented Across Key Categories?

The phosphoramidite market covered in this report is segmented –

1) By Type: Deoxyribonucleic Acid (DNA) Phosphoramidites, Ribonucleic Acid (RNA) Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites, Other Types

2) By Synthesis Method: H-Phosphonate Method, Phosphoramidite Method, Trivalent Phosphorus Compounds Method

3) By Application: Gene Synthesis, Deoxyribonucleic Acid (DNA) Sequencing, Deoxyribonucleic Acid (DNA) Amplification

4) By End-User: Academic Research, Pharmaceutical Industry, Biotechnology Industry

Subsegments:

1) By Deoxyribonucleic Acid (DNA) Phosphoramidites: Standard DNA Phosphoramidites, Degenerate DNA Phosphoramidites, Methylated DNA Phosphoramidites, Backbone-Modified DNA Phosphoramidites

2) By Ribonucleic Acid (RNA) Phosphoramidites: Standard RNA Phosphoramidites, 2′-O-Methyl RNA Phosphoramidites, 2′-Fluoro RNA Phosphoramidites, 2′-O-TBDMS Protected RNA Phosphoramidites

3) By Labeled Phosphoramidites: Fluorescent-Labeled Phosphoramidites, Biotin-Labeled Phosphoramidites, Digoxigenin-Labeled Phosphoramidites, Radioisotope-Labeled Phosphoramidites

4) By Modifier Phosphoramidites: Amine-Modified Phosphoramidites, Thiol-Modified Phosphoramidites, Spacer Phosphoramidites, Azide-Modified Phosphoramidites

5) By Other Types: Chimeric Phosphoramidites, Phosphorothioate Phosphoramidites, PEGylated Phosphoramidites, Photo-Cleavable Phosphoramidites

Which Upcoming Trends Are Expected To Influence The Phosphoramidite Market?

Leading entities within the phosphoramidite market are prioritizing the creation of advanced DNA synthesis methods, such as convertible-preferred stock financing rounds, to boost the implementation and advancement of Gibson SOLA technology for quick DNA and mRNA synthesis. This type of financing involves a company securing funds by issuing preferred shares, which possess the option to be converted into a set quantity of common shares at a future date. An illustrative example is from March 2025, when Telesis Bio Inc., a biotechnology firm based in the US, disclosed it had obtained new funding totaling up to $21 million. This capital injection is intended to hasten the market introduction of its innovative enzymatic DNA synthesis platform, Gibson SOLA, backed by various strategic investors. The purpose of these funds is to scale up the company’s entirely enzymatic DNA synthesis technology, expand its research and development as well as manufacturing capacities, and increase availability for fast, customizable production of long DNA. The firm employs a unique enzymatic strategy that facilitates the swift and accurate synthesis of extended DNA sequences, thereby resolving existing limitations linked to conventional phosphoramidite-based techniques.

Who Are The Dominant Players Shaping The Phosphoramidite Market Landscape?

Major companies operating in the phosphoramidite market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Aragen Life Sciences, Twist Bioscience, Innovassynth Technologies (I) Ltd., Tokyo Chemical Industry Co. Ltd. (TCI), Aurigene Services, Eurofins Genomics, LGC Biosearch Technologies, Link Technologies Ltd., Creative Biolabs, Biosynth Carbosynth, TriLink BioTechnologies, ChemGenes Corporation, Berry & Associates Inc., Lumiprobe Corporation, Hongene Biotech Corporation, Carbolink India Pvt. Ltd., PolyOrg Inc., Glen Research, Gene Link Inc., emp BIOTECH GmbH

Read the full phosphoramidite market report here:

https://www.thebusinessresearchcompany.com/report/phosphoramidite-global-market-report

Which Region Is Projected To Dominate The Phosphoramidite Market During The Forecast Period?

North America was the largest region in the phosphoramidite market in 2025. Europe is expected to be the fastest-growing region during the forecast period. The regions covered in the phosphoramidite market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Phosphoramidite Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=22096&type=smp

Browse Through More Reports Similar to the Global Phosphoramidite Market 2026, By The Business Research Company

Phosgene Market Report 2026

https://www.thebusinessresearchcompany.com/report/phosgene-global-market-report

Phosphoric Acid Market Report 2026

https://www.thebusinessresearchcompany.com/report/phosphoric-acid-global-market-report

Phosphonates Market Report 2026

https://www.thebusinessresearchcompany.com/report/phosphonates-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Phosphoramidite Market Over The 2026–2030 Period?

The phosphoramidite market has experienced robust expansion over the past few years. It is projected to expand from $1.07 billion in 2025 to $1.15 billion by 2026, registering a compound annual growth rate (CAGR) of 7.1%. Historically, this growth can be attributed to an increase in DNA sequencing activities, the expansion of academic research funding, a greater use of synthetic nucleic acids, the development of solid-phase synthesis techniques, and rising demand for molecular diagnostics.

The phosphoramidite market size is anticipated to experience robust expansion over the coming years. This market is projected to reach a valuation of $1.5 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.9%. Key drivers for this growth during the projection period include the broadening scope of RNA-based therapeutics, advancements in gene editing technologies, heightened investment in pharmaceutical research and development, an increasing need for custom oligonucleotides, and the expansion of automated synthesis platforms. Significant trends identified for the forecast timeframe encompass an escalating requirement for oligonucleotide synthesis materials, the enlargement of gene therapy and RNA therapeutics applications, wider incorporation into diagnostic and research uses, increasing integration of automated solid-phase synthesis methods, and a sharpened emphasis on chemical inputs of high purity.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22096&type=smp

What Underlying Factors Are Accelerating The Growth Of The Phosphoramidite Market?

The expanding biopharmaceutical sector is anticipated to drive the future growth of the phosphoramidite market. This sector refers to the industry engaged in the research, development, production, and commercialization of biologically derived medical products, encompassing vaccines, gene therapies, monoclonal antibodies, and recombinant proteins. The expansion of the biopharmaceutical sector is a result of advancements in biotechnology, the increasing prevalence of chronic diseases, and greater investments in research and development. Biotechnology innovations, such as gene editing and monoclonal antibody therapies, have led to more effective and targeted treatments. For instance, in October 2025, the Office for National statistics, a UK-based government department, reported that in 2024, the UK life sciences industry consisted of 6,170 businesses operating across 7,320 sites, employing 359,600 people, and generating $191 billion (£146.9 billion) in turnover. The medical technology subsector was the largest by both company count and workforce, accounting for 60% of all companies and 55% of total employment. Thus, the growth of the phosphoramidite market is being propelled by the expansion of the biopharmaceutical sector.

How Is The Phosphoramidite Market Segmented Across Key Categories?

The phosphoramidite market covered in this report is segmented –

1) By Type: Deoxyribonucleic Acid (DNA) Phosphoramidites, Ribonucleic Acid (RNA) Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites, Other Types

2) By Synthesis Method: H-Phosphonate Method, Phosphoramidite Method, Trivalent Phosphorus Compounds Method

3) By Application: Gene Synthesis, Deoxyribonucleic Acid (DNA) Sequencing, Deoxyribonucleic Acid (DNA) Amplification

4) By End-User: Academic Research, Pharmaceutical Industry, Biotechnology Industry

Subsegments:

1) By Deoxyribonucleic Acid (DNA) Phosphoramidites: Standard DNA Phosphoramidites, Degenerate DNA Phosphoramidites, Methylated DNA Phosphoramidites, Backbone-Modified DNA Phosphoramidites

2) By Ribonucleic Acid (RNA) Phosphoramidites: Standard RNA Phosphoramidites, 2′-O-Methyl RNA Phosphoramidites, 2′-Fluoro RNA Phosphoramidites, 2′-O-TBDMS Protected RNA Phosphoramidites

3) By Labeled Phosphoramidites: Fluorescent-Labeled Phosphoramidites, Biotin-Labeled Phosphoramidites, Digoxigenin-Labeled Phosphoramidites, Radioisotope-Labeled Phosphoramidites

4) By Modifier Phosphoramidites: Amine-Modified Phosphoramidites, Thiol-Modified Phosphoramidites, Spacer Phosphoramidites, Azide-Modified Phosphoramidites

5) By Other Types: Chimeric Phosphoramidites, Phosphorothioate Phosphoramidites, PEGylated Phosphoramidites, Photo-Cleavable Phosphoramidites

Which Upcoming Trends Are Expected To Influence The Phosphoramidite Market?

Leading entities within the phosphoramidite market are prioritizing the creation of advanced DNA synthesis methods, such as convertible-preferred stock financing rounds, to boost the implementation and advancement of Gibson SOLA technology for quick DNA and mRNA synthesis. This type of financing involves a company securing funds by issuing preferred shares, which possess the option to be converted into a set quantity of common shares at a future date. An illustrative example is from March 2025, when Telesis Bio Inc., a biotechnology firm based in the US, disclosed it had obtained new funding totaling up to $21 million. This capital injection is intended to hasten the market introduction of its innovative enzymatic DNA synthesis platform, Gibson SOLA, backed by various strategic investors. The purpose of these funds is to scale up the company’s entirely enzymatic DNA synthesis technology, expand its research and development as well as manufacturing capacities, and increase availability for fast, customizable production of long DNA. The firm employs a unique enzymatic strategy that facilitates the swift and accurate synthesis of extended DNA sequences, thereby resolving existing limitations linked to conventional phosphoramidite-based techniques.

Who Are The Dominant Players Shaping The Phosphoramidite Market Landscape?

Major companies operating in the phosphoramidite market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Aragen Life Sciences, Twist Bioscience, Innovassynth Technologies (I) Ltd., Tokyo Chemical Industry Co. Ltd. (TCI), Aurigene Services, Eurofins Genomics, LGC Biosearch Technologies, Link Technologies Ltd., Creative Biolabs, Biosynth Carbosynth, TriLink BioTechnologies, ChemGenes Corporation, Berry & Associates Inc., Lumiprobe Corporation, Hongene Biotech Corporation, Carbolink India Pvt. Ltd., PolyOrg Inc., Glen Research, Gene Link Inc., emp BIOTECH GmbH

Read the full phosphoramidite market report here:

https://www.thebusinessresearchcompany.com/report/phosphoramidite-global-market-report

Which Region Is Projected To Dominate The Phosphoramidite Market During The Forecast Period?

North America was the largest region in the phosphoramidite market in 2025. Europe is expected to be the fastest-growing region during the forecast period. The regions covered in the phosphoramidite market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Phosphoramidite Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=22096&type=smp

Browse Through More Reports Similar to the Global Phosphoramidite Market 2026, By The Business Research Company

Phosgene Market Report 2026

https://www.thebusinessresearchcompany.com/report/phosgene-global-market-report

Phosphoric Acid Market Report 2026

https://www.thebusinessresearchcompany.com/report/phosphoric-acid-global-market-report

Phosphonates Market Report 2026

https://www.thebusinessresearchcompany.com/report/phosphonates-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Phosphoramidite Market Over The 2026–2030 Period?

The phosphoramidite market has experienced robust expansion over the past few years. It is projected to expand from $1.07 billion in 2025 to $1.15 billion by 2026, registering a compound annual growth rate (CAGR) of 7.1%. Historically, this growth can be attributed to an increase in DNA sequencing activities, the expansion of academic research funding, a greater use of synthetic nucleic acids, the development of solid-phase synthesis techniques, and rising demand for molecular diagnostics.

The phosphoramidite market size is anticipated to experience robust expansion over the coming years. This market is projected to reach a valuation of $1.5 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.9%. Key drivers for this growth during the projection period include the broadening scope of RNA-based therapeutics, advancements in gene editing technologies, heightened investment in pharmaceutical research and development, an increasing need for custom oligonucleotides, and the expansion of automated synthesis platforms. Significant trends identified for the forecast timeframe encompass an escalating requirement for oligonucleotide synthesis materials, the enlargement of gene therapy and RNA therapeutics applications, wider incorporation into diagnostic and research uses, increasing integration of automated solid-phase synthesis methods, and a sharpened emphasis on chemical inputs of high purity.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22096&type=smp

What Underlying Factors Are Accelerating The Growth Of The Phosphoramidite Market?

The expanding biopharmaceutical sector is anticipated to drive the future growth of the phosphoramidite market. This sector refers to the industry engaged in the research, development, production, and commercialization of biologically derived medical products, encompassing vaccines, gene therapies, monoclonal antibodies, and recombinant proteins. The expansion of the biopharmaceutical sector is a result of advancements in biotechnology, the increasing prevalence of chronic diseases, and greater investments in research and development. Biotechnology innovations, such as gene editing and monoclonal antibody therapies, have led to more effective and targeted treatments. For instance, in October 2025, the Office for National statistics, a UK-based government department, reported that in 2024, the UK life sciences industry consisted of 6,170 businesses operating across 7,320 sites, employing 359,600 people, and generating $191 billion (£146.9 billion) in turnover. The medical technology subsector was the largest by both company count and workforce, accounting for 60% of all companies and 55% of total employment. Thus, the growth of the phosphoramidite market is being propelled by the expansion of the biopharmaceutical sector.

How Is The Phosphoramidite Market Segmented Across Key Categories?

The phosphoramidite market covered in this report is segmented –

1) By Type: Deoxyribonucleic Acid (DNA) Phosphoramidites, Ribonucleic Acid (RNA) Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites, Other Types

2) By Synthesis Method: H-Phosphonate Method, Phosphoramidite Method, Trivalent Phosphorus Compounds Method

3) By Application: Gene Synthesis, Deoxyribonucleic Acid (DNA) Sequencing, Deoxyribonucleic Acid (DNA) Amplification

4) By End-User: Academic Research, Pharmaceutical Industry, Biotechnology Industry

Subsegments:

1) By Deoxyribonucleic Acid (DNA) Phosphoramidites: Standard DNA Phosphoramidites, Degenerate DNA Phosphoramidites, Methylated DNA Phosphoramidites, Backbone-Modified DNA Phosphoramidites

2) By Ribonucleic Acid (RNA) Phosphoramidites: Standard RNA Phosphoramidites, 2′-O-Methyl RNA Phosphoramidites, 2′-Fluoro RNA Phosphoramidites, 2′-O-TBDMS Protected RNA Phosphoramidites

3) By Labeled Phosphoramidites: Fluorescent-Labeled Phosphoramidites, Biotin-Labeled Phosphoramidites, Digoxigenin-Labeled Phosphoramidites, Radioisotope-Labeled Phosphoramidites

4) By Modifier Phosphoramidites: Amine-Modified Phosphoramidites, Thiol-Modified Phosphoramidites, Spacer Phosphoramidites, Azide-Modified Phosphoramidites

5) By Other Types: Chimeric Phosphoramidites, Phosphorothioate Phosphoramidites, PEGylated Phosphoramidites, Photo-Cleavable Phosphoramidites

Which Upcoming Trends Are Expected To Influence The Phosphoramidite Market?

Leading entities within the phosphoramidite market are prioritizing the creation of advanced DNA synthesis methods, such as convertible-preferred stock financing rounds, to boost the implementation and advancement of Gibson SOLA technology for quick DNA and mRNA synthesis. This type of financing involves a company securing funds by issuing preferred shares, which possess the option to be converted into a set quantity of common shares at a future date. An illustrative example is from March 2025, when Telesis Bio Inc., a biotechnology firm based in the US, disclosed it had obtained new funding totaling up to $21 million. This capital injection is intended to hasten the market introduction of its innovative enzymatic DNA synthesis platform, Gibson SOLA, backed by various strategic investors. The purpose of these funds is to scale up the company’s entirely enzymatic DNA synthesis technology, expand its research and development as well as manufacturing capacities, and increase availability for fast, customizable production of long DNA. The firm employs a unique enzymatic strategy that facilitates the swift and accurate synthesis of extended DNA sequences, thereby resolving existing limitations linked to conventional phosphoramidite-based techniques.

Who Are The Dominant Players Shaping The Phosphoramidite Market Landscape?

Major companies operating in the phosphoramidite market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Aragen Life Sciences, Twist Bioscience, Innovassynth Technologies (I) Ltd., Tokyo Chemical Industry Co. Ltd. (TCI), Aurigene Services, Eurofins Genomics, LGC Biosearch Technologies, Link Technologies Ltd., Creative Biolabs, Biosynth Carbosynth, TriLink BioTechnologies, ChemGenes Corporation, Berry & Associates Inc., Lumiprobe Corporation, Hongene Biotech Corporation, Carbolink India Pvt. Ltd., PolyOrg Inc., Glen Research, Gene Link Inc., emp BIOTECH GmbH

Read the full phosphoramidite market report here:

https://www.thebusinessresearchcompany.com/report/phosphoramidite-global-market-report

Which Region Is Projected To Dominate The Phosphoramidite Market During The Forecast Period?

North America was the largest region in the phosphoramidite market in 2025. Europe is expected to be the fastest-growing region during the forecast period. The regions covered in the phosphoramidite market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Phosphoramidite Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=22096&type=smp

Browse Through More Reports Similar to the Global Phosphoramidite Market 2026, By The Business Research Company

Phosgene Market Report 2026

https://www.thebusinessresearchcompany.com/report/phosgene-global-market-report

Phosphoric Acid Market Report 2026

https://www.thebusinessresearchcompany.com/report/phosphoric-acid-global-market-report

Phosphonates Market Report 2026

https://www.thebusinessresearchcompany.com/report/phosphonates-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the phosphoramidite market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the Phosphoramidite Market expected to reach by 2030?

The phosphoramidite market has witnessed substantial growth in recent years. Its size is expected to increase from $1.07 billion in 2025 to $1.15 billion in 2026, at a compound annual growth rate (CAGR) of 7.1%. The expansion observed historically stems from factors such as increased DNA sequencing activities, an expansion of academic research funding, the broader application of synthetic nucleic acids, advancements in solid-phase synthesis techniques, and a growing demand for molecular diagnostics.

The phosphoramidite market is projected to experience substantial growth in the upcoming years, with expectations to reach $1.5 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.9%. This anticipated growth can be attributed to factors such as the expansion of RNA-based therapeutics, advancements in gene editing technologies, increased pharmaceutical R&D investment, a rising demand for custom oligonucleotides, and the scaling of automated synthesis platforms. Prominent trends throughout the forecast period include a heightened demand for oligonucleotide synthesis materials, the broadening scope of gene therapy and RNA therapeutics, their increasing application in diagnostic and research settings, the growing adoption of automated solid-phase synthesis, and an intensified focus on high-purity chemical inputs.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22096&type=smp

What Drivers Are Driving Adoption Within The Phosphoramidite Market?

The burgeoning biopharmaceutical sector is projected to drive the future expansion of the phosphoramidite market. This sector encompasses the industry dedicated to the research, development, manufacturing, and marketing of medical products originating from biological sources, such as vaccines, gene therapies, monoclonal antibodies, and recombinant proteins. Its growth is attributable to progress in biotechnology, a greater incidence of chronic illnesses, and increased funding in research and development. Groundbreaking biotechnology developments, including gene editing and monoclonal antibody therapies, have led to the creation of more effective and precise treatments. As an illustration, the Office for National Statistics, a UK-based government department, stated in October 2025 that the UK life sciences industry in 2024 consisted of 6,170 businesses across 7,320 locations, providing employment for 359,600 individuals and achieving a turnover of $191 billion (£146.9 billion). Medical technology emerged as the leading subsector, both in terms of company numbers and workforce size, accounting for 60% of all companies and 55% of total employment. Consequently, the expanding biopharmaceutical sector is indeed propelling the growth of the phosphoramidite market.

How Is The Phosphoramidite Market Organized Into Various Segments?

The phosphoramidite market covered in this report is segmented –

1) By Type: Deoxyribonucleic Acid (DNA) Phosphoramidites, Ribonucleic Acid (RNA) Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites, Other Types

2) By Synthesis Method: H-Phosphonate Method, Phosphoramidite Method, Trivalent Phosphorus Compounds Method

3) By Application: Gene Synthesis, Deoxyribonucleic Acid (DNA) Sequencing, Deoxyribonucleic Acid (DNA) Amplification

4) By End-User: Academic Research, Pharmaceutical Industry, Biotechnology Industry

Subsegments:

1) By Deoxyribonucleic Acid (DNA) Phosphoramidites: Standard DNA Phosphoramidites, Degenerate DNA Phosphoramidites, Methylated DNA Phosphoramidites, Backbone-Modified DNA Phosphoramidites

2) By Ribonucleic Acid (RNA) Phosphoramidites: Standard RNA Phosphoramidites, 2′-O-Methyl RNA Phosphoramidites, 2′-Fluoro RNA Phosphoramidites, 2′-O-TBDMS Protected RNA Phosphoramidites

3) By Labeled Phosphoramidites: Fluorescent-Labeled Phosphoramidites, Biotin-Labeled Phosphoramidites, Digoxigenin-Labeled Phosphoramidites, Radioisotope-Labeled Phosphoramidites

4) By Modifier Phosphoramidites: Amine-Modified Phosphoramidites, Thiol-Modified Phosphoramidites, Spacer Phosphoramidites, Azide-Modified Phosphoramidites

5) By Other Types: Chimeric Phosphoramidites, Phosphorothioate Phosphoramidites, PEGylated Phosphoramidites, Photo-Cleavable Phosphoramidites

What Trends Are Reshaping The Dynamics Of The Phosphoramidite Market?

Leading companies in the phosphoramidite market are prioritizing the development of advanced DNA synthesis methods, including convertible-preferred stock financing rounds, to enhance the adoption and progress of Gibson SOLA technology for efficient DNA and mRNA synthesis. Convertible-preferred stock financing refers to a method for raising capital where a company issues preferred shares that can subsequently be exchanged for a predetermined quantity of common shares. For example, in March 2025, Telesis Bio Inc., a US-based biotechnology company, announced it had secured up to $21 million in new financing. This funding aims to expedite the commercialization of its next-generation enzymatic DNA synthesis platform, Gibson SOLA, with backing from several strategic investors. The investment is intended to scale the company’s fully enzymatic DNA synthesis technology, expand its R&D and manufacturing capabilities, and broaden access to rapid, customizable long-DNA production. The company utilizes a proprietary enzymatic approach that allows for the fast and precise synthesis of long DNA sequences, addressing existing bottlenecks associated with traditional phosphoramidite-based methods.

Who Are The Top-Performing Companies In The Phosphoramidite Market In Recent Years?

Major companies operating in the phosphoramidite market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Aragen Life Sciences, Twist Bioscience, Innovassynth Technologies (I) Ltd., Tokyo Chemical Industry Co. Ltd. (TCI), Aurigene Services, Eurofins Genomics, LGC Biosearch Technologies, Link Technologies Ltd., Creative Biolabs, Biosynth Carbosynth, TriLink BioTechnologies, ChemGenes Corporation, Berry & Associates Inc., Lumiprobe Corporation, Hongene Biotech Corporation, Carbolink India Pvt. Ltd., PolyOrg Inc., Glen Research, Gene Link Inc., emp BIOTECH GmbH

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/phosphoramidite-global-market-report

Which Region Currently Holds The Largest Share Of The Phosphoramidite Market?

North America was the largest region in the phosphoramidite market in 2025. Europe is expected to be the fastest-growing region during the forecast period. The regions covered in the phosphoramidite market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Phosphoramidite Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=22096&type=smp

Browse Through More Reports Similar to the Global Phosphoramidite Market 2026, By The Business Research Company

Phosgene Market Report 2026

https://www.thebusinessresearchcompany.com/report/phosgene-global-market-report

Phosphoric Acid Market Report 2026

https://www.thebusinessresearchcompany.com/report/phosphoric-acid-global-market-report

Phosphonates Market Report 2026

https://www.thebusinessresearchcompany.com/report/phosphonates-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the nutraceutical excipients market from 2025–2034 with trusted insights from The Business Research Company

What Is The Base Market Size For The Nutraceutical Excipients Market Today And What Will It Reach By 2029?

The phosphoramidite market size has demonstrated robust growth in recent years. This market is set to expand from $1.01 billion in 2024 to $1.07 billion in 2025, achieving a compound annual growth rate (CAGR) of 6.1%. The historical growth trajectory can be attributed to factors such as the increasing demand for DNA and RNA synthesis, the rising adoption of mRNA-based therapeutics, the growing prevalence of genetic disorders, the expanding demand for synthetic biology, and enhanced investments in genomic research.

The phosphoramidite market is poised for significant expansion in the coming years. Projections indicate it will reach $1.4 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 7.0%. This anticipated growth during the forecast period is primarily driven by the increasing application of phosphoramidites, a surge in demand for tailored DNA and RNA synthesis, the escalating requirement for high-purity phosphoramidites, an intensified emphasis on personalized medicine, and the proliferation of biopharmaceutical firms. Key trends shaping the forecast period encompass the expansion of synthetic biology, the creation of innovative phosphoramidite chemistries, progress in genomic technologies, ongoing development efforts within biotechnology, and the evolution of personalized medicine.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22096&type=smp

What Factors Are Boosting The Nutraceutical Excipients Market?

The growth of the phosphoramidite market is expected to be propelled by the expanding biopharmaceutical sector going forward. This sector encompasses the industry involved in the research, development, production, and commercialization of medical products derived from biological sources, such as vaccines, gene therapies, monoclonal antibodies, and recombinant proteins. The expansion of the biopharmaceutical sector is attributed to advancements in biotechnology, the increasing prevalence of chronic diseases, and rising investments in research and development. Innovations in biotechnology, including gene editing and monoclonal antibody therapies, have led to more effective and targeted treatments. The burgeoning biopharmaceutical sector will boost phosphoramidite demand, as these compounds play a crucial role in synthesizing DNA and RNA for gene therapies, mRNA vaccines, and oligonucleotide-based drugs. As these treatments gain wider adoption, the requirement for phosphoramidites to produce synthetic nucleic acids will increase, thereby enhancing their use in biopharmaceutical research and production. For example, according to the UK government, the core biopharmaceutical sector generated £46.7 ($58.4 billion) billion in revenue during 2022, accounting for 43% of the life sciences industry’s total turnover. Additionally, this sector supports over 126,000 jobs and has shown substantial growth in research and development investments. Consequently, the expansion of the biopharmaceutical sector is a key driver for the growth of the phosphoramidite market.

How Is The Nutraceutical Excipients Market Categorized By Application, Type, And Region?

The phosphoramidite market covered in this report is segmented –

1) By Type: Deoxyribonucleic Acid (DNA) Phosphoramidites, Ribonucleic Acid (RNA) Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites, Other Types

2) By Synthesis Method: H-Phosphonate Method, Phosphoramidite Method, Trivalent Phosphorus Compounds Method

3) By Application: Gene Synthesis, Deoxyribonucleic Acid (DNA) Sequencing, Deoxyribonucleic Acid (DNA) Amplification

4) By End-User: Academic Research, Pharmaceutical Industry, Biotechnology Industry

Subsegments:

1) By Deoxyribonucleic Acid (DNA) Phosphoramidites: Standard DNA Phosphoramidites, Degenerate DNA Phosphoramidites, Methylated DNA Phosphoramidites, Backbone-Modified DNA Phosphoramidites

2) By Ribonucleic Acid (RNA) Phosphoramidites: Standard RNA Phosphoramidites, 2′-O-Methyl RNA Phosphoramidites, 2′-Fluoro RNA Phosphoramidites, 2′-O-TBDMS Protected RNA Phosphoramidites

3) By Labeled Phosphoramidites: Fluorescent-Labeled Phosphoramidites, Biotin-Labeled Phosphoramidites, Digoxigenin-Labeled Phosphoramidites, Radioisotope-Labeled Phosphoramidites

4) By Modifier Phosphoramidites: Amine-Modified Phosphoramidites, Thiol-Modified Phosphoramidites, Spacer Phosphoramidites, Azide-Modified Phosphoramidites

5) By Other Types: Chimeric Phosphoramidites, Phosphorothioate Phosphoramidites, PEGylated Phosphoramidites, Photo-Cleavable Phosphoramidites

How Are Technological Trends Affecting The Nutraceutical Excipients Market Growth?

Major companies operating in the phosphoramidite market are concentrating on developing advanced DNA synthesis services aimed at boosting accuracy, speed, and sustainability while reducing hazardous waste in DNA manufacturing. DNA synthesis represents a method for creating DNA sequences utilizing enzymes instead of chemical reagents, thus providing greater accuracy, speed, and sustainability. For instance, in April 2022, Ansa Biotechnologies Inc., a US-based biotechnology company, announced the completion of an oversubscribed $68 million Series A financing round. This funding initiative was led by Northpond Ventures and saw participation from various new and existing investors. The capital secured is intended to accelerate the advancement of Ansa’s next-generation enzymatic DNA synthesis technology, also known as phosphoramidite synthesis, to expand its R&D and manufacturing facilities, and to launch a customizable DNA synthesis service. The company, which spun out from the University of California, Berkeley, employs a patented technique that enables the rapid and precise synthesis of long DNA sequences, thereby addressing existing industry bottlenecks.

Who Are The Global Leaders Steering The Nutraceutical Excipients Market Forward?

Major companies operating in the phosphoramidite market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Aragen Life Sciences, Twist Bioscience, Innovassynth Technologies (I) Ltd., Tokyo Chemical Industry Co. Ltd. (TCI), Aurigene Services, Eurofins Genomics, LGC Biosearch Technologies, Link Technologies Ltd., Creative Biolabs, Biosynth Carbosynth, TriLink BioTechnologies, ChemGenes Corporation, Berry & Associates Inc., Lumiprobe Corporation, Hongene Biotech Corporation, Carbolink India Pvt. Ltd., PolyOrg Inc., Glen Research, Gene Link Inc., emp BIOTECH GmbH

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/phosphoramidite-global-market-report

Which Region Is Projected To Achieve The Fastest Growth In The Nutraceutical Excipients Market?

North America was the largest region in the phosphoramidite market in 2024. Europe is expected to be the fastest-growing region during the forecast period. The regions covered in the phosphoramidite market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=22096&type=smp

Browse Through More Reports Similar to the Global Nutraceutical Excipients Market 2025, By The Business Research Company

Viral Vectors And Plasmid Dna Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/viral-vectors-and-plasmid-dna-global-market-report

Dna Based Skin Care Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dna-based-skin-care-products-global-market-report

Dna And Gene Chip Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dna-and-gene-chip-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

How Much Will The Phosphoramidite Market Be Worth By 2029?

In recent times, there has been notable progress in the phosphoramidite market size. The expectation is a leap from $1.01 billion in 2024 to $1.07 billion in 2025, revealing a compound annual growth rate (CAGR) of 6.1%. Several influences led to this growth during the historic period, including a surge in demand for DNA and RNA synthesis, greater use of mRNA-based treatments, increasing cases of genetic disorders, an escalated demand in synthetic biology, and an uptick in investments towards genomic research.

In the coming years, the phosphoramidite market is anticipated to witness substantial growth, swelling to a size of “$1.4 billion in 2029” with a compound annual growth rate (CAGR) of 7.0%. This growth trajectory during the forecast period is linked to factors such as increased use of phosphoramidites, heightened demand for customized DNA and RNA synthesis, rising requirement for high-purity phosphoramidites, the growing focus on personalized medicine, and the expansion of biopharmaceutical firms. Trend indicators for the forecast period include the spread of synthetic biology, the creation of unique phosphoramidite chemistries, advancements in genomic technologies, development endeavours in the biotechnology field, and the progress of personalized medicine.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22096&type=smp

What Are The Primary Factors Supporting The Phosphoramidite Market Expansion?

The phosphoramidite market is set to witness significant growth due to the expanding biopharmaceutical sector. The biopharmaceutical sector entails industries involved in the R&D, manufacturing, and commercialization of medical products derived biologically, including recombinant proteins, monoclonal antibodies, gene therapies, and vaccines. Factors like advancements in biotechnology, a high occurrence of chronic illnesses, and increased investment in R&D are fuelling this growth. Biotech breakthroughs such as monoclonal antibody treatments and gene editing have paved the way for targeted and more efficient therapies. Phosphoramidite, being crucial in the synthesis of RNA and DNA for mRNA vaccines, gene therapies, and oligonucleotide-based drugs, will see increased demand with the expansion of the biopharmaceutical sector. As these therapies gain popularity, the requirement for phosphoramidites in producing synthetic nucleic acids will heighten, thus, amplifying their application in biopharmaceutical research and production. For instance, the UK government states that the core biopharmaceutical sector generated £46.7 ($58.4 billion) billion in revenue in 2022, accounting for 43% of the total turnover of the life sciences industry. Moreover, it supports over 126,000 jobs and has seen significant growth in R&D investments. Consequently, the growing biopharmaceutical sector is propelling the phosphoramidite market’s expansion.

How Does The Phosphoramidite Market Differ By Segment?

The phosphoramidite market covered in this report is segmented –

1) By Type: Deoxyribonucleic Acid (DNA) Phosphoramidites, Ribonucleic Acid (RNA) Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites, Other Types

2) By Synthesis Method: H-Phosphonate Method, Phosphoramidite Method, Trivalent Phosphorus Compounds Method

3) By Application: Gene Synthesis, Deoxyribonucleic Acid (DNA) Sequencing, Deoxyribonucleic Acid (DNA) Amplification

4) By End-User: Academic Research, Pharmaceutical Industry, Biotechnology Industry

Subsegments:

1) By Deoxyribonucleic Acid (DNA) Phosphoramidites: Standard DNA Phosphoramidites, Degenerate DNA Phosphoramidites, Methylated DNA Phosphoramidites, Backbone-Modified DNA Phosphoramidites

2) By Ribonucleic Acid (RNA) Phosphoramidites: Standard RNA Phosphoramidites, 2′-O-Methyl RNA Phosphoramidites, 2′-Fluoro RNA Phosphoramidites, 2′-O-TBDMS Protected RNA Phosphoramidites

3) By Labeled Phosphoramidites: Fluorescent-Labeled Phosphoramidites, Biotin-Labeled Phosphoramidites, Digoxigenin-Labeled Phosphoramidites, Radioisotope-Labeled Phosphoramidites

4) By Modifier Phosphoramidites: Amine-Modified Phosphoramidites, Thiol-Modified Phosphoramidites, Spacer Phosphoramidites, Azide-Modified Phosphoramidites

5) By Other Types: Chimeric Phosphoramidites, Phosphorothioate Phosphoramidites, PEGylated Phosphoramidites, Photo-Cleavable Phosphoramidites

What New Opportunities Are Emerging From Trends In The Phosphoramidite Market?

Leading firms in the phosphoramidite market are prioritizing the development of innovative DNA synthesis services to improve efficiency, speed, and sustainability, while also minimizing hazardous waste produced during DNA production. Enzymes, rather than chemical reagents, are used in the DNA synthesis method, resulting in heightened accuracy, speed, and sustainability. For example, in April 2022, Ansa Biotechnologies Inc., a biotech firm based in the US, declared the completion of a $68 million Series A financing round that was oversubscribed. Northpond Ventures led this round, which received support from a range of both new and existing investors. The purpose of this funding is to expedite the progress of Ansa’s subsequent enzymatic DNA synthesis technology, also known as phosphoramidite synthesis, develop its R&D and manufacturing infrastructure, and initiate a tailored DNA synthesis service. The company, which evolved from the University of California, Berkeley, employs a patented technique enabling quick and precise long DNA sequence synthesis, addressing current industry challenges.

Who Are The Global Leaders Steering The Phosphoramidite Market Forward?

Major companies operating in the phosphoramidite market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Aragen Life Sciences, Twist Bioscience, Innovassynth Technologies (I) Ltd., Tokyo Chemical Industry Co. Ltd. (TCI), Aurigene Services, Eurofins Genomics, LGC Biosearch Technologies, Link Technologies Ltd., Creative Biolabs, Biosynth Carbosynth, TriLink BioTechnologies, ChemGenes Corporation, Berry & Associates Inc., Lumiprobe Corporation, Hongene Biotech Corporation, Carbolink India Pvt. Ltd., PolyOrg Inc., Glen Research, Gene Link Inc., emp BIOTECH GmbH

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/phosphoramidite-global-market-report

Which Region Is Likely To Register The Fastest Growth In The Phosphoramidite Market?

North America was the largest region in the phosphoramidite market in 2024. Europe is expected to be the fastest-growing region during the forecast period. The regions covered in the phosphoramidite market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=22096&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model